Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics, and therapeutic activity of GI-101/GI-101A as a single agent or in combination with pembrolizumab, lenvatinib or local radiotherapy (RT) over a range of advanced and/or metastatic solid tumors.
Sponsor: GI Innovation, Inc.
Check if you qualify for this advanced solid tumors clinical trial in New York, NY
If you're searching for advanced solid tumors treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.